title: Surgical resection versus open-approach radiofrequency ablation for small hepatocellular carcinomas within Milan criteria after successful transcatheter arterial chemoembolization.
abstract: OBJECTIVE
  The aim of this study was to compare the effectiveness and safety of hepatic resection versus open-approach RFA (ORFA) for small hepatocellular carcinomas (HCC) within Milan criteria after successful downstaging therapy by transcatheter arterial chemoembolization.
  
  
  METHODS
  Between February 2005 and February 2008, a total of 110 patients with advanced HCC met the Milan criteria after successful downstaging therapy; 58 patients then underwent hepatic resection and 52 received ORFA. Outcomes, including short- and long-term morbidity, 1-, 3-, and 5-year mortality and HCC-free survival, were analyzed and compared between the two groups.
  
  
  RESULTS
  Patients in the hepatic resection and ORFA groups showed similar baseline characteristics and downstaging protocols. The ORFA group showed less blood loss, lower hospital costs, shorter surgical time, and fewer hospital stay days (P < 0.05). The 1-, 3-, and 5-year overall survival rates were 94.8, 86.2, and 79.3%, respectively, with liver resection and 96.2, 82.7, and 76.9% with ORFA (P=0.772). The 1-, 3-, and 5-year recurrence-free survival rates were 93.1, 81.0, and 77.6% with resection and 94.2, 76.9, and 73.1% with ORFA (P=0.705). The ORFA patients suffered fewer postoperative complications (P=0.09), particularly among the cases of central HCC (P=0.015).
  
  
  CONCLUSIONS
  Resection and ORFA achieved similar survival benefits in the management of HCC within Milan criteria after successful downstaging. The decreased blood loss, hospital costs, surgical time, and hospital stay days, and lower complication rates in central cases render ORFA a preferred treatment option.
authors: Jianyong
authors: J
authors: Lei
authors: Wentao
authors: W
authors: Wang
authors: Lunan
authors: L
authors: Yan
mesh_terms: D000328:Adult; D006528:Carcinoma, Hepatocellular / Q000401:mortality / Q000473:pathology / Q000601:surgery* / Q000628:therapy; D017115:Catheter Ablation / Q000009:adverse effects; D002404:Catheterization; D016461:Chemoembolization, Therapeutic / Q000379:methods; D003131:Combined Modality Therapy; D005260:Female; D006498:Hepatectomy / Q000009:adverse effects; D006801:Humans; D008113:Liver Neoplasms / Q000401:mortality / Q000473:pathology / Q000601:surgery* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D012074:Remission Induction; D012189:Retrospective Studies; D015996:Survival Rate
references: J Gastrointest Surg. 2011 Feb;15(2):311-20
references: 21052859
references: J Gastrointest Surg. 2008 Sep;12(9):1521-6
references: 18592325
references: World J Surg. 2010 Nov;34(11):2671-6
references: 20645090
references: Hepatology. 2010 Apr;51(4):1284-90
references: 20099299
references: Semin Liver Dis. 1999;19(3):271-85
references: 10518307
references: Am J Transplant. 2008 Dec;8(12):2547-57
references: 19032223
references: Hepatology. 2011 May;53(5):1580-9
references: 21351114
references: Liver Transpl. 2008 Mar;14(3):272-8
references: 18306328
references: Ann Surg. 2010 Dec;252(6):903-12
references: 21107100
references: World J Gastroenterol. 2006 Jan 28;12(4):546-52
references: 16489666
references: Ann Surg. 2008 Oct;248(4):617-25
references: 18936575
references: Hepatology. 2008 Jan;47(1):82-9
references: 18008357
references: Cancer. 2003 Mar 1;97(5):1253-62
references: 12599233
references: Liver Transpl. 2007 Feb;13(2):272-9
references: 17256758
references: Am J Transplant. 2005 Apr;5(4 Pt 1):795-804
references: 15760404
references: Br J Surg. 2007 Jan;94(1):78-86
references: 17016793
references: Gastroenterology. 2005 Jul;129(1):122-30
references: 16012942
references: J Hepatobiliary Pancreat Surg. 2009;16(3):359-66
references: 19300896
references: N Engl J Med. 1991 Sep 5;325(10):675-80
references: 1651452
references: Cancer Imaging. 2012 Apr 05;12:79-88
references: 22487698
references: World J Surg. 2012 Jan;36(1):151-6
references: 22030561
references: J Gastroenterol Hepatol. 1991 Jul-Aug;6(4):408-13
references: 1655100
references: CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90
references: 21296855
references: Ann Surg. 1997 Dec;226(6):688-701; discussion 701-3
references: 9409568
references: J Gastrointest Surg. 2005 Jan;9(1):62-7; discussion 67-8
references: 15623446
references: Hepatology. 2008 Sep;48(3):819-27
references: 18688876
references: Ann Surg. 2009 Apr;249(4):617-23
references: 19300227
references: Cancer. 2012 Jan 1;118(1):147-56
references: 21713764
references: Cancer. 2000 Feb 15;88(4):912-20
references: 10679662
references: Semin Liver Dis. 2010 Feb;30(1):52-60
references: 20175033
references: Radiology. 2012 Mar;262(3):1022-33
references: 22357902
references: J Clin Gastroenterol. 2006 Oct;40(9):842-6
references: 17016142
references: Hepatology. 2006 May;43(5):1101-8
references: 16628706
references: Ann Surg. 2006 Mar;243(3):321-8
references: 16495695
references: J Gastrointest Surg. 2012 Nov;16(11):2120-5
references: 22948843
references: Hepatology. 2010 Apr;51(4):1116-8
references: 20373366
references: Surgery. 2008 Apr;143(4):469-75
references: 18374043
references: Hepatol Int. 2011 Jun;5(2):722-9
references: 21484104
references: Hepatology. 2005 Nov;42(5):1208-36
references: 16250051
references: J Gastroenterol. 2003;38(10):977-81
references: 14614605
references: J Clin Gastroenterol. 2005 Mar;39(3):247-52
references: 15718869